Back to Search Start Over

Platelet Acetyl-CoA Carboxylase Phosphorylation: A Risk Stratification Marker That Reveals Platelet-Lipid Interplay in Coronary Artery Disease Patients.

Authors :
Kautbally S
Lepropre S
Onselaer MB
Le Rigoleur A
Ginion A
De Meester de Ravenstein C
Ambroise J
Boudjeltia KZ
Octave M
Wéra O
Hego A
Pincemail J
Cheramy-Bien JP
Huby T
Giera M
Gerber B
Pouleur AC
Guigas B
Vanoverschelde JL
Kefer J
Bertrand L
Oury C
Horman S
Beauloye C
Source :
JACC. Basic to translational science [JACC Basic Transl Sci] 2019 Sep 11; Vol. 4 (5), pp. 596-610. Date of Electronic Publication: 2019 Sep 11 (Print Publication: 2019).
Publication Year :
2019

Abstract

Adenosine monophosphate-activated protein kinase (AMPK) acetyl-CoA carboxylase (ACC) signaling is activated in platelets by atherogenic lipids, particularly by oxidized low-density lipoproteins, through a CD36-dependent pathway. More interestingly, increased platelet AMPK-induced ACC phosphorylation is associated with the severity of coronary artery calcification as well as acute coronary events in coronary artery disease patients. Therefore, AMPK-induced ACC phosphorylation is a potential marker for risk stratification in suspected coronary artery disease patients. The inhibition of ACC resulting from its phosphorylation impacts platelet lipid content by down-regulating triglycerides, which in turn may affect platelet function.<br /> (© 2019 The Authors.)

Details

Language :
English
ISSN :
2452-302X
Volume :
4
Issue :
5
Database :
MEDLINE
Journal :
JACC. Basic to translational science
Publication Type :
Academic Journal
Accession number :
31768476
Full Text :
https://doi.org/10.1016/j.jacbts.2019.04.005